Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000556470 | SCV000630710 | uncertain significance | Gastrointestinal stromal tumor; Paragangliomas 4; Pheochromocytoma | 2023-11-08 | criteria provided, single submitter | clinical testing | This variant, c.478_480del, results in the deletion of 1 amino acid(s) of the SDHB protein (p.Lys160del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (no rsID available, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with SDHB-related conditions. ClinVar contains an entry for this variant (Variation ID: 459150). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV001023034 | SCV001184849 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-01-09 | criteria provided, single submitter | clinical testing | The c.478_480delAAG variant (also known as p.K160del) is located in coding exon 5 of the SDHB gene. This variant results from an in-frame AAG deletion at nucleotide positions 478 to 480. This results in the in-frame deletion of a lysine at codon 160. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Baylor Genetics | RCV003476238 | SCV004203003 | uncertain significance | Gastrointestinal stromal tumor | 2024-02-16 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV004791526 | SCV005409187 | uncertain significance | not provided | 2024-08-20 | criteria provided, single submitter | clinical testing | PM4 |